PL3400000T3 - Sposoby podawania angiotensyny ii - Google Patents

Sposoby podawania angiotensyny ii

Info

Publication number
PL3400000T3
PL3400000T3 PL17736407.2T PL17736407T PL3400000T3 PL 3400000 T3 PL3400000 T3 PL 3400000T3 PL 17736407 T PL17736407 T PL 17736407T PL 3400000 T3 PL3400000 T3 PL 3400000T3
Authority
PL
Poland
Prior art keywords
methods
administering angiotensin
angiotensin
administering
Prior art date
Application number
PL17736407.2T
Other languages
English (en)
Inventor
George Tidmarsh
Lakhmir Chawla
Original Assignee
La Jolla Pharma, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59273945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3400000(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by La Jolla Pharma, Llc filed Critical La Jolla Pharma, Llc
Publication of PL3400000T3 publication Critical patent/PL3400000T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/085Angiotensins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G01N2410/02Angiotensins; Related peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
PL17736407.2T 2016-01-07 2017-01-06 Sposoby podawania angiotensyny ii PL3400000T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276171P 2016-01-07 2016-01-07
US201662347292P 2016-06-08 2016-06-08
PCT/US2017/012485 WO2017120438A1 (en) 2016-01-07 2017-01-06 Methods for administering angiotensin ii

Publications (1)

Publication Number Publication Date
PL3400000T3 true PL3400000T3 (pl) 2024-04-22

Family

ID=59273945

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17736407.2T PL3400000T3 (pl) 2016-01-07 2017-01-06 Sposoby podawania angiotensyny ii

Country Status (11)

Country Link
US (3) US10406201B2 (pl)
EP (1) EP3400000B1 (pl)
JP (1) JP2019501201A (pl)
KR (2) KR20180108639A (pl)
AU (2) AU2017205168A1 (pl)
BR (1) BR112018013847A2 (pl)
CA (1) CA3010781A1 (pl)
ES (1) ES2973280T3 (pl)
PL (1) PL3400000T3 (pl)
TW (1) TW201733610A (pl)
WO (1) WO2017120438A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
PL3400000T3 (pl) 2016-01-07 2024-04-22 La Jolla Pharma, Llc Sposoby podawania angiotensyny ii
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
WO2021092057A1 (en) * 2019-11-04 2021-05-14 The Regents Of The University Of California Artificial intelligence enabled control of hemodynamics in surgery patients

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
CA2448051A1 (en) 2001-06-04 2002-12-12 Human Genome Sciences, Inc. Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
JP2007510643A (ja) 2003-11-06 2007-04-26 ジーイー・ヘルスケア・アクスイェ・セルスカプ 医薬化合物
EP1942985B1 (en) 2005-09-29 2011-04-27 Fibrogen, Inc. Methods for reducing blood pressure
WO2007076572A1 (en) 2005-12-30 2007-07-12 Howard Florey Institute Of Experimental Physiology And Medicine A method of treatment
EP2029137A2 (en) * 2006-06-15 2009-03-04 Gilead Colorado, Inc. Antihypertensive therapy method
CA2678131A1 (en) 2006-11-17 2008-05-22 Antoine Andremont Colonic delivery using zn/pectin beads with a eudragit coating.
AU2009319856A1 (en) 2008-11-28 2010-06-03 Abbvie Inc. Stable antibody compositions and methods for stabilizing same
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
BR112013000744A2 (pt) 2010-07-14 2020-07-14 Cumberland Emerging Technologies, Inc uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas
JP6522584B2 (ja) 2013-04-26 2019-05-29 ラ ホヤ ファーマシューティカル カンパニーLa Jolla Pharmaceutical Company 腎不全を処置するための組成物及び方法
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
EP3381465A1 (en) 2014-07-08 2018-10-03 La Jolla Pharmaceutical Company Methods for treating hypotension
WO2017120440A1 (en) 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods of administering vasopressors
PL3400000T3 (pl) 2016-01-07 2024-04-22 La Jolla Pharma, Llc Sposoby podawania angiotensyny ii
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法

Also Published As

Publication number Publication date
ES2973280T3 (es) 2024-06-19
US20210030834A1 (en) 2021-02-04
US20170224761A1 (en) 2017-08-10
AU2024201059A1 (en) 2024-03-07
JP2019501201A (ja) 2019-01-17
US20210187058A1 (en) 2021-06-24
CA3010781A1 (en) 2017-07-13
BR112018013847A2 (pt) 2018-12-18
US11219662B2 (en) 2022-01-11
US10406201B2 (en) 2019-09-10
WO2017120438A1 (en) 2017-07-13
EP3400000B1 (en) 2023-12-06
EP3400000A1 (en) 2018-11-14
EP3400000A4 (en) 2019-07-31
KR20180108639A (ko) 2018-10-04
KR20250174727A (ko) 2025-12-12
TW201733610A (zh) 2017-10-01
AU2017205168A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
SG11201802794PA (en) Therapeutic compounds and methods
SG10201912416QA (en) Therapeutic agents
PT3132034T (pt) Terapêutica
GB201509893D0 (en) Therapeutic agents
GB201616839D0 (en) Therapeutic compounds
GB201517263D0 (en) Therapeutic agents
GB201410816D0 (en) Therapeutic agents
GB201415569D0 (en) Therapeutic Compounds
ZA201805046B (en) Therapeutic compounds
GB201410216D0 (en) Therapeutic
GB201509885D0 (en) Therapeutic agents
GB201410817D0 (en) Therapeutic agents
GB201410815D0 (en) Therapeutic agents
PL3400000T3 (pl) Sposoby podawania angiotensyny ii
GB201509888D0 (en) Therapeutic agents
GB201617339D0 (en) Therapeutic compounds
IL263821A (en) Medicinal compounds
GB201513299D0 (en) Therapeutic agents
GB201510637D0 (en) Therapeutic
GB201416273D0 (en) Therapeutic compounds
GB2538767B (en) Coffin
GB201521767D0 (en) Therapeutic agents
SG11201700059WA (en) Therapeutic agent for keratoconjunctive disorder
GB201517264D0 (en) Therapeutic agents
GB201410334D0 (en) Therapeutic